SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories’ arm recalls 18,960 bottles of hypertension drug in US

06 Oct 2022 Evaluate

Unichem Laboratories’ subsidiary -- Unichem Pharmaceuticals USA Inc is recalling 18,960 bottles of the hypertension treatment medication Clonidine Hydrochloride tablets in the American market. The recall is due to product mix-up.

As per the US Food and Drug Administration (USFDA), 0.2 mg strength Clonidine Hydrochloride Tablets, USP were found in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets. The affected lot of tables have been manufactured by Unichem Laboratories in its Goa based plant and distributed in the US market by New Jersey-based Unichem Pharmaceuticals USA Inc.

As per the USFDA, the company has initiated the Class III recall on September 19 across the US.A Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’. According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019. It is the largest market globally for pharmaceutical products.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×